Inscobee Inc.
SEC CIK 2057997 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc. | 10% | 2.06M | $2.00M | — | 4 | 2025-05-12 | 2025-05-12 |
Most active insiders at APUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Inscobee Inc. made no open-market trades at APUS in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2025-06-11 | 2025-05-12 | APUS | Apimeds Pharmaceuticals US, Inc. | Inscobee Inc. | 10% | C - Cnv Deriv | $2.60 | +115.1K | 2.06M | +6% | +$299.3K |
| D | 2025-05-14 | 2025-05-12 | APUS | Apimeds Pharmaceuticals US, Inc. | Inscobee Inc. | 10% | C - Cnv Deriv | $2.60 | +44.0K | 2.03M | +2% | +$114.5K |
| DMI | 2025-05-14 | 2025-05-12 | APUS | Apimeds Pharmaceuticals US, Inc. | Inscobee Inc. | 10% | C - Cnv Deriv | $2.60 | +253.1K | 4.32M | +6% | +$658.0K |
| D | 2025-05-14 | 2025-05-12 | APUS | Apimeds Pharmaceuticals US, Inc. | Inscobee Inc. | 10% | P - Purchase | $4.00 | +500.0K | 1.98M | +34% | +$2.00M |
Purchase Sale Sale after option exercise All abbreviations